What is TRVI's dilution risk score?

TRVI has a latest available DilutionScore record of 14/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for TRVI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for TRVI?

DilutionWatch tracks 25 SEC filing types for TRVI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect TRVI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For TRVI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for TRVI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for TRVI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

TRVI Dilution Risk Score: 14/100 (LOW)

Score Breakdown

📋 Offering Ability

32

💰 Cash Runway

0

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for TRVI.

🔔 Track TRVI — Get forecast alerts →

Market Data

Market Cap$2.01B

Shares Outstanding142.48M

Float117.83M

Cash$318.87M

DebtN/A

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	14/100	DilutionWatch score record
Shares Outstanding	142.48M	Verified float table or market cache
Public Float	117.83M	Verified float table or market cache
Market Cap	$2.01B	Market data cache
Cash Runway	78.4 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 16.0% shares (2026Q1 vs prior)

201 institutional holders · 154.93M shares

#1 NEA Management Company, LLC 13.22M shares

#2 BlackRock, Inc. 10.24M shares

#3 Vivo Capital, LLC 10.19M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.01M

Days to Cover8.0

% of Float10.2%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2019-12-31

4 INSIDER TRANSACTION 2026-02-20

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual TRVI Dilution Snapshot

Trevi Therapeutics, Inc. (TRVI) has a DilutionScore of 14/100, rated Low dilution risk. Score date: September 12, 2026.

Recent SEC activity tracked for TRVI: 4 on 2026-02-20; 4 on 2026-02-20; 4 on 2026-02-20.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.